Exact Mass: 545.1477186000001

Exact Mass Matches: 545.1477186000001

Found 272 metabolites which its exact mass value is equals to given mass value 545.1477186000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Man(a3)Man(b4)GlcNAc

alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosamine

C20H35NO16 (545.1955750000001)


   

alpha-D-Galactosyl-N-acetyllactosamine

alpha-D-Galactosyl-N-acetyllactosamine

C20H35NO16 (545.1955750000001)


   

dTDP-beta-L-4-epi-vancosamine

dTDP-L-epivancosamine; dTDP-beta-L-4-epi-vancosamine; dTDP-3-amino-2,3,6-trideoxy-3-methyl-beta-L-arabino-hexopyranose

C17H29N3O13P2 (545.1175564)


   
   

Alvelestat

Alvelestat

C25H22F3N5O4S (545.1344528000001)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Doxorubicinol

(8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-8-[(1S)-1,2-dihydroxyethyl]-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C27H31NO11 (545.1897016)


Doxorubicinol belongs to the family of Anthracyclines. These are polyketides containing a tetracenequinone ring structure with a sugar attached by glycosidic linkage.

   

Lacto-N-triaose

N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidate

C20H35NO16 (545.1955750000001)


Human beta-1,3-N-acetylglucosaminyltransferase 2 (beta3GnT2) converts lacto-N-triose II into lacto-N-tetraose and lacto-N-neotetraose. (PMID:16277601).

   

Lacto-N-triose I

N-[5-Hydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}oxan-3-yl]ethanimidate

C20H35NO16 (545.1955750000001)


Lacto-N-triose I is found in milk and milk products. Lacto-N-triose I is isolated from the partial acid hydrolysis of human milk. Isolated from the partial acid hydrolysis of human milk. Lacto-N-triose I is found in milk and milk products.

   

N-Acetylgalactosaminyl lactose

N-[(2R,3R,4R,5R,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C20H35NO16 (545.1955750000001)


N-Acetylgalactosaminyl lactose is a trisaccharide obtained from bovine colostrum. A trisaccharide obtained from bovine colostrum

   

4-{[4-(Diethylamino)phenyl](2,4-disulfophenyl)methylene}-N,N-diethyl-2,5-cyclohexadien-1-iminium

4-{[4-(diethylamino)phenyl](2,4-disulphophenyl)methylidene}-N,N-diethylcyclohexa-2,5-dien-1-iminium

C27H33N2O6S2 (545.1779938000001)


4-{[4-(Diethylamino)phenyl](2,4-disulfophenyl)methylene}-N,N-diethyl-2,5-cyclohexadien-1-iminium belongs to the family of Diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. (http://en.wikipedia.org/wiki/Diphenylmethane)

   

Doxorubicinol aglycone

10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8-(1,2-dihydroxyethyl)-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C27H31NO11 (545.1897016)


Doxorubicinol aglycone is a metabolite of doxorubicin. Doxorubicin is a drug used in cancer chemotherapy. It is an anthracycline antibiotic, closely related to the natural product daunomycin, and like all anthracyclines, it works by intercalating DNA. Doxorubicin is commonly used in the treatment of a wide range of cancers, including hematological malignancies, many types of carcinoma, and soft tissue sarcomas. Doxorubicins most serious adverse effect is life-threatening heart damage. (Wikipedia)

   

alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

N-(5-{[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl)ethanimidate

C20H35NO16 (545.1955750000001)


   

Alvelestat

N-((5-(Methanesulfonyl)pyridin-2-yl)methyl)-6-methyl-5-(1-methyl-1H-pyrazol-5-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide

C25H22F3N5O4S (545.1344528000001)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Gal-alpha1,4Gal-beta1,4-GlcNAc

N-(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl)ethanimidate

C20H35NO16 (545.1955750000001)


   

5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one

5-{3-[7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-4-yl]prop-2-yn-1-yl}-5,6-dihydrophenanthridin-6-one

C31H20ClN5OS (545.1077020000001)


   

THOS Streptonigrin

5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-{5-hydroxy-4-methoxy-2,2-dimethyl-2H-imidazo[4,5-h]quinolin-8-yl}-3-methylpyridine-2-carboxylic acid

C28H27N5O7 (545.1910392)


   

Adafosbuvir

Propan-2-yl 2-[({[2-fluoro-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)-4-methyloxolan-2-yl]methoxy}(phenoxy)phosphoryl)amino]propanoic acid

C22H29FN3O10P (545.1574516)


   
   
   
   
   
   

6-O-[2-Acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-b-D-glucopyranosyl]-D-galactopyranose

6-O-[2-Acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-b-D-glucopyranosyl]-D-galactopyranose

C20H35NO16 (545.1955750000001)


   

O3-(2-acetylamino-O3-beta-D-galactopyranosyl-2-deoxy-beta-D-glucopyranosyl)-D-galactose|O3-(2-Acetylamino-O3-beta-D-galactopyranosyl-2-desoxy-beta-D-glucopyranosyl)-D-galactose

O3-(2-acetylamino-O3-beta-D-galactopyranosyl-2-deoxy-beta-D-glucopyranosyl)-D-galactose|O3-(2-Acetylamino-O3-beta-D-galactopyranosyl-2-desoxy-beta-D-glucopyranosyl)-D-galactose

C20H35NO16 (545.1955750000001)


   
   
   
   

N-Ac-2-Amino-2-deoxy-beta-D-glucopyranosyl-(1?3)-beta-D-galactopyranosyl-(1?4)-D-glucose

N-Ac-2-Amino-2-deoxy-beta-D-glucopyranosyl-(1?3)-beta-D-galactopyranosyl-(1?4)-D-glucose

C20H35NO16 (545.1955750000001)


   
   
   

Cys Phe Asn Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C25H31N5O7S (545.1944096)


   

Cys Phe Tyr Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C25H31N5O7S (545.1944096)


   

Cys Asn Phe Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C25H31N5O7S (545.1944096)


   

Cys Asn Tyr Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanoic acid

C25H31N5O7S (545.1944096)


   

Cys Tyr Phe Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C25H31N5O7S (545.1944096)


   

Cys Tyr Asn Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C25H31N5O7S (545.1944096)


   

Phe Cys Asn Tyr

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C25H31N5O7S (545.1944096)


   

Phe Cys Tyr Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C25H31N5O7S (545.1944096)


   

Phe Asn Cys Tyr

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C25H31N5O7S (545.1944096)


   

Phe Asn Tyr Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C25H31N5O7S (545.1944096)


   

Phe Tyr Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C25H31N5O7S (545.1944096)


   

Phe Tyr Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C25H31N5O7S (545.1944096)


   

Asn Cys Phe Tyr

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C25H31N5O7S (545.1944096)


   

Asn Cys Tyr Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanoic acid

C25H31N5O7S (545.1944096)


   

Asn Phe Cys Tyr

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C25H31N5O7S (545.1944096)


   

Asn Phe Tyr Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C25H31N5O7S (545.1944096)


   

Asn Tyr Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C25H31N5O7S (545.1944096)


   

Asn Tyr Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C25H31N5O7S (545.1944096)


   

Tyr Cys Phe Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C25H31N5O7S (545.1944096)


   

Tyr Cys Asn Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C25H31N5O7S (545.1944096)


   

Tyr Phe Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C25H31N5O7S (545.1944096)


   

Tyr Phe Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C25H31N5O7S (545.1944096)


   

Tyr Asn Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C25H31N5O7S (545.1944096)


   

Tyr Asn Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C25H31N5O7S (545.1944096)


   

Lacto-N-triaose

O-2-(Acetylamino)-2-deoxy-beta-delta-glucopyranosyl-(1->3)-O-beta-delta-galactopyranosyl-(1->4)-delta-glucose

C20H35NO16 (545.1955750000001)


   
   

Doxorubicinol

Doxorubicinol

C27H31NO11 (545.1897016)


A member of the class of tetracenequinones that is the major metabolite of the anthracycline doxorubicin, a chemotherapeutic agent effective against a broad range of malignant neoplasms. It is thought to exhibit cardiotoxic properties.

   

Isopropylidene Azastreptonigrin

Isopropylidene Azastreptonigrin

C28H27N5O7 (545.1910392)


   

Lacto-N-triose I

N-[5-hydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}oxan-3-yl]acetamide

C20H35NO16 (545.1955750000001)


   

N-Acetylgalactosaminyl lactose

N-[(2R,3R,4R,5R,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C20H35NO16 (545.1955750000001)


   

CP-945598 HCl

Otenabant hydrochloride

C25H26Cl3N7O (545.1264316)


C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   

4-O-(6-O-[2-Acetamido-2-deoxy-b-D-glucopyranosyl]-b-D-galactopyranosyl)-D-glucopyranose

4-O-(6-O-[2-ACETAMIDO-2-DEOXY-BETA-D-GLUCO-PYRANOSYL]-BETA-D-GALACTO-PYRANOSYL)-D-GLUCO-PYRANOSE

C20H35NO16 (545.1955750000001)


   

betaLacNAc

2-ACETAMIDO-2-DEOXY-4-O-([4-O-BETA-D-GALACTOPYRANOSYL]-BETA-D-GALACTOPYRANOSYL)-D-GLUCOPYRANOSE

C20H35NO16 (545.1955750000001)


   
   

Sufrexal

Ketanserin tartrate

C26H28FN3O9 (545.180949)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Ketanserin (R41468) tartrate is a selective 5-HT2 receptor antagonist. Ketanserin tartrate also blocks hERG current (IhERG) in a concentration-dependent manner (IC50=0.11 μM).

   

3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione

3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione

C28H24F5N3O3 (545.1737734)


   

4-nitrophenyl 2-acetamido-3-o-(2-acetamido-2-deoxy-b-d-glucopyranosyl)-2-deoxy-a-d-galactopyranoside

4-nitrophenyl 2-acetamido-3-o-(2-acetamido-2-deoxy-b-d-glucopyranosyl)-2-deoxy-a-d-galactopyranoside

C22H31N3O13 (545.1856796)


   

4-Nitrophenyl 2-acetamido-6-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-2-deoxy-α-D-galactopyranoside

4-Nitrophenyl 2-acetamido-6-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-2-deoxy-α-D-galactopyranoside

C22H31N3O13 (545.1856796)


   

GalNAc beta(1-3)GlcNAc-beta-pNP

GalNAc beta(1-3)GlcNAc-beta-pNP

C22H31N3O13 (545.1856796)


   

p-nitrophenyl beta-d-n,n-diacetylchitobiose

4-Nitrophenyl N,N-Diacetyl-beta-D-chitobioside

C22H31N3O13 (545.1856796)


   

Uprifosbuvir

Uprifosbuvir

C22H29ClN3O9P (545.1329864)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

O-2-(Acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-alpha-D-galactopyranosyl-(1-4)-D-glucose

O-2-(Acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-alpha-D-galactopyranosyl-(1-4)-D-glucose

C20H35NO16 (545.1955750000001)


   

5-Chloro-N,N-bis[2-(ethoxy carbonyloxy) ethyl]-2-methoxy-4-(5-nitro-1,3-thiazol-2-ylazo) aniline

5-Chloro-N,N-bis[2-(ethoxy carbonyloxy) ethyl]-2-methoxy-4-(5-nitro-1,3-thiazol-2-ylazo) aniline

C20H24ClN5O9S (545.0983204)


   

Adafosbuvir

Propan-2-yl 2-[[[5-(2,4-dioxopyrimidin-1-yl)-2-fluoro-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate

C22H29FN3O10P (545.1574516)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor

   

Gefapixant citrate

Gefapixant citrate

C20H27N5O11S (545.1427712000001)


C78272 - Agent Affecting Nervous System > C177180 - P2X Purinoreceptor Antagonist

   

5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one

5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one

C31H20ClN5OS (545.1077020000001)


   

[4-[[4-(Diethylamino)phenyl]-(2,4-disulfophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene]-diethylazanium

[4-[[4-(Diethylamino)phenyl]-(2,4-disulfophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene]-diethylazanium

C27H33N2O6S2+ (545.1779938000001)


   

alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-GlcNAc

alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-GlcNAc

C20H35NO16 (545.1955750000001)


   

N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide

N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide

C20H35NO16 (545.1955750000001)


   

beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-D-Gal

beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-D-Gal

C20H35NO16 (545.1955750000001)


   

alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

C20H35NO16 (545.1955750000001)


   

4-{[4-(Diethylamino)phenyl](2,5-disulfophenyl)methylidene}-N,N-diethylcyclohexa-2,5-dien-1-iminium

4-{[4-(Diethylamino)phenyl](2,5-disulfophenyl)methylidene}-N,N-diethylcyclohexa-2,5-dien-1-iminium

C27H33N2O6S2+ (545.1779938000001)


   

alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

N-(5-{[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl)ethanimidate

C20H35NO16 (545.1955750000001)


   
   

afrormosin-7-O-glucoside-6-O-malonate

afrormosin-7-O-glucoside-6-O-malonate

C26H25O13- (545.12951)


   

alpha-D-galactosyl-(1,3)-beta-D-galactosyl-(1,4)-N-acetyl-D-glucosamine

alpha-D-galactosyl-(1,3)-beta-D-galactosyl-(1,4)-N-acetyl-D-glucosamine

C20H35NO16 (545.1955750000001)


   
   
   

beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp

beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp

C20H35NO16 (545.1955750000001)


   

N-[(2S,3R,4R,5S,6R)-2-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3S,4S,5S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

N-[(2S,3R,4R,5S,6R)-2-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3S,4S,5S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C20H35NO16 (545.1955750000001)


   
   
   
   
   

beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

C20H35NO16 (545.1955750000001)


   

alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc

alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc

C20H35NO16 (545.1955750000001)


   

4-[(2E)-2-[(3-Methyl-1-phenyl-5-pyrrolidin-1-ylpyrazol-4-yl)methylidene]hydrazinyl]-3-nitro-N-phenylbenzenesulfonamide

4-[(2E)-2-[(3-Methyl-1-phenyl-5-pyrrolidin-1-ylpyrazol-4-yl)methylidene]hydrazinyl]-3-nitro-N-phenylbenzenesulfonamide

C27H27N7O4S (545.1845142000001)


   

N-[[(4S,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-(1-piperidinyl)propanamide

N-[[(4S,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-(1-piperidinyl)propanamide

C23H36BrN3O5S (545.1558906)


   

N-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-(1-piperidinyl)propanamide

N-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-(1-piperidinyl)propanamide

C23H36BrN3O5S (545.1558906)


   
   
   
   
   
   
   

N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C20H35NO16 (545.1955750000001)


   

N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C20H35NO16 (545.1955750000001)


   

N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]oxan-3-yl]acetamide

N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]oxan-3-yl]acetamide

C20H35NO16 (545.1955750000001)


   
   
   
   
   
   

N-acetyl-alpha-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose

N-acetyl-alpha-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose

C20H35NO16 (545.1955750000001)


   

beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->6)-D-mannopyranose

beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->6)-D-mannopyranose

C20H35NO16 (545.1955750000001)


   

beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-D-Gal

beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-D-Gal

C20H35NO16 (545.1955750000001)


   

alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-D-glucosamine

alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-D-glucosamine

C20H35NO16 (545.1955750000001)


   

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)-beta-D-galactose

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)-beta-D-galactose

C20H35NO16 (545.1955750000001)


   
   
   

beta-D-Glcp-(1->6)-beta-D-GlcpNAc-(1->3)-beta-D-Galp

beta-D-Glcp-(1->6)-beta-D-GlcpNAc-(1->3)-beta-D-Galp

C20H35NO16 (545.1955750000001)


   

alpha-D-Gal-(1->4)-beta-D-Gal-(1->3)-alpha-D-GalNAc

alpha-D-Gal-(1->4)-beta-D-Gal-(1->3)-alpha-D-GalNAc

C20H35NO16 (545.1955750000001)


   

beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-beta-D-GlcpNAc

beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-beta-D-GlcpNAc

C20H35NO16 (545.1955750000001)


   

alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-NHAc

alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-NHAc

C20H35NO16 (545.1955750000001)


   

alpha-D-Gal-(1->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc

alpha-D-Gal-(1->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc

C20H35NO16 (545.1955750000001)


   

(3R,3R,4S,6R,8S,8aS)-6-(4-hydroxyphenyl)-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

(3R,3R,4S,6R,8S,8aS)-6-(4-hydroxyphenyl)-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

C33H27N3O5 (545.1950612)


   
   
   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2,2,2-trifluoroethylsulfonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2,2,2-trifluoroethylsulfonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C20H30F3N3O7S2 (545.1477186000001)


   
   
   
   
   

alpha-D-Galp-(1->4)-beta-D-GalpNAc-(1->4)-D-Galp

alpha-D-Galp-(1->4)-beta-D-GalpNAc-(1->4)-D-Galp

C20H35NO16 (545.1955750000001)


   
   
   
   

alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-GalpNAc

alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-GalpNAc

C20H35NO16 (545.1955750000001)


   
   
   
   

N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-galactosyl-(1->3)-D-galactose

N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-galactosyl-(1->3)-D-galactose

C20H35NO16 (545.1955750000001)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-D-manno-hexopyranose

D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-D-manno-hexopyranose

C20H35NO16 (545.1955750000001)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-beta-D-manno-hexopyranose

D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-beta-D-manno-hexopyranose

C20H35NO16 (545.1955750000001)


   

D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-alpha-D-manno-hexopyranose

D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-alpha-D-manno-hexopyranose

C20H35NO16 (545.1955750000001)


   
   
   
   

2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose

2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose

C20H35NO16 (545.1955750000001)


A linear amino trisaccharide comprising of 2-acetamido-2-deoxy-beta-D-glucopyranosyl residue (1->3)-linked to a beta-D-galactosyl residue, which is in turn linked (1->4) to D-glucose.